First Horizon Advisors, Inc. Seres Therapeutics, Inc. Transaction History

First Horizon Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$4.67 - $6.55 $4,203 - $5,895	900 New	900 $4,000
Q2 2022 Aug 02, 2022	BUY	$2.7 - $7.62 $774 - $2,186	287 New	287 $0
Q3 2021 Nov 09, 2021	SELL	$5.46 - $22.6 $5,307 - $21,967	-972 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$18.46 - $24.36 $5,833 - $7,697	316 Added 48.17%	972 $23,000
Q1 2021 May 11, 2021	BUY	$17.66 - $28.92 $11,584 - $18,971	656 New	656 $13,000

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $68.2M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.